Cardiac impact of the arteriovenous fistula after kidney transplantation: A case-controlled, match-paired study

Transplant International

Volumn 21, Issue 10, 2008, Pages 948-954

  Cridlig, Joëlle ^b   Selton Suty, Christine ^b   Alla, François ^b   Chodek, Anne ^b   Pruna, Alice ^b   Kessler, Michèle ^b   Frimat, Luc ^a,b  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Arteriovenous fistula; Kidney transplantation; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM ANTAGONIST; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD FLOW; CARDIOVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART INDEX; HEART LEFT ATRIUM; HEART LEFT VENTRICLE MASS; HEART RIGHT ATRIUM; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLE; VASCULAR ACCESS;

ADULT; AGED; CATHETERS, INDWELLING; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 51349114251     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00707.x     Document Type: Article

References (27)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med 2004 351 : 1296.
2. De Simone G, Pasanisi F, Contaldo F. Link of non hemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 2001 38 : 13.
3. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996 11 : 1277.
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995 47 : 186.
5. London G. Pathophysiology of cardiovascular damage in the earlyl renal population. Nephrol Dial Transplant 2001 16 : 3.
6. Hüting J, Kramer W, Schütterle G, Wizemann V. Analysis of left ventricular changes associated with chronic hemodialysis. Nephron 1988 49 : 284.
7. Hüting J, Alpert MA. Progression of left ventricular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension end hypercirculation. Clin Cardiol 1992 15 : 190.
8. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004 66 : 2386.
9. Frimat L, Durand PY, Loos-Ayav C, et al. Impact of the first dialysis modality on outcomes of patients contraindicated for kidney transplantation. Perit Dial Int 2006 26 : 231.
10. Peteiro J, Alvarez N, Calvino R, Penas M, Ribera F, Castro Beirs A. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed doppler study. Cardiology 1994 85 : 273.
11. Ferreira SRC, Moises VA, Tavares A, Pacheco-Silva A. Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation 2002 74 : 1580.
12. Hüting J. Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 1992 70 : 1481.
13. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant patients. Am J Med 1988 84 : 985.
14. Munclinger M, Nemecek K, Serf B, Vondracek V, Hrudova J. Effect of arteriovenous fistula creation and maturation on rest hemodynamics in patients with end-stage renal disease. Nephron 1987 46 : 105.
15. Crowley ST, Morrissey RL, Silvermann ED, Yudt WM, Hirszel P. Renal hemodynamic response to the creation of vascular access in patients with end-stage renal disease. Ren Fail 1995 17 : 589.
16. Ori Y, Korzets A, Katz M, Perek Y, Yahavi I, Gafter U. The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy. Am J Kidney Dis 2002 40 : 745.
17. Van Duijnhoven ECM, Cheriex ECM, Tordoir JHM, Kooman JP, Van Hooff JP. Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant 2001 16 : 368.
18. Unger P, Wissing KM, De Pauw L, Neubauer J, Van de Borne P. Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation 2002 74 : 73.
19. De Lima JJ, Vieira ML, Molnar LJ, Medeiros CJ, Ianhez LA, Krieger EM. Cardiac effects of persistent hemodialysis arteriovenous access in recipients of renal allograft. Cardiology 1999 92 : 236.
20. Sahn DJ, De Maria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American society of echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978 58 : 1072.
21. Lemmers MJ, Bary JM. Major roles for arterial disease in morbidity and mortality after kidney transplantation in diabetic recipients. Diabetes Care 1991 14 : 295.
22. Fenton SSA, Schaubel DE, Desmeules M. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997 30 : 334.
23. Unger P, Velez-Roa S, Wissing KM, Dung Hoang A, van de Borne P. Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. Am J Transplant 2004 4 : 2038.
24. Aurigemma GP, Devereux RB, Wachtell K. Left ventricular mass regression in the LIFE study: effect of previous anti hypertensive treatment. Am J Hypertens 2003 16 : 180.
25. Sheashaa H, Hassan N, Osman Y, Sabry A, Sobh M. Effect of spontaneous closure of arteriovenous fistula acccess on cardiac structure and function in renal transplant patients. Am J Nephrol 2004 24 : 432.
26. Wijnen E, Keuter XH, Planken NR, et al. The relation between vascular access flow and different types of vascular access with systemic hemodynamics in hemodialysis patients. Artif Organs 2005 29 : 960.
27. Ventura HO, Lavie CJ, Messerli FH. Cardiovascular adaptation to cyclosporine-induced hypertension. J Hum Hypertens 1994 8 : 233.